Nkarta NKTX
NASDAQ NKTX
$2.66 +0.19 (+7.69%)
At close: Aug 21, 2026 · 4:00 PM EDT

Nkarta (NKTX) Long-Term Investments (2023 - 2026)

Nkarta (NKTX) posted quarterly Long-Term Investments of $33.6 million for Q1 2026, down 59.87% year-over-year from $83.7 million in Q1 2025, and up 108.41% quarter-over-quarter from $16.1 million in Q4 2025.

Nkarta (NKTX) Long-Term Investments (2023 - 2026) Analysis & Trends

Nkarta's Long-Term Investments history runs 4 years deep, the most recent figure standing at $33.6 million for Q1 2026.

  • In Q1 2026, Long-Term Investments fell 59.87% year-over-year to $33.6 million; the TTM figure through Mar 2026 stood at $33.6 million (down 59.87% YoY), while the FY2025 annual figure was $16.1 million, down 85.41% from the prior year.
  • Long-Term Investments for Q1 2026 stood at $33.6 million, up from $16.1 million in the prior quarter.
  • The five-year high for Long-Term Investments was $119.5 million in Q3 2024, with the low at $6.0 million in Q1 2023.
  • The 4-year median for Long-Term Investments is $33.6 million (2026), against an average of $51.8 million.
  • Peak annual rise in Long-Term Investments reached 752.36% in 2025, while the deepest fall reached 85.41% in 2025.
  • Nkarta's Long-Term Investments stood at $18.7 million in 2023, then surged by 489.45% to $110.4 million in 2024, then slumped by 85.41% to $16.1 million in 2025, then jumped by 108.41% to $33.6 million in 2026.
  • Business Quant data shows NKTX's Long-Term Investments at $33.6 million in Q1 2026, $16.1 million in Q4 2025, and $31.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 5.79 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 9.83 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1.77 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 22.17 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - 372.10 Mn
10 Nkarta 201.14 Mn 201.14 Mn - 57.67 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 57.67 Mn
Mar 31, 2026 33.57 Mn
Dec 31, 2025 16.11 Mn
Sep 30, 2025 31.42 Mn
Jun 30, 2025 41.61 Mn
Mar 31, 2025 83.65 Mn
Dec 31, 2024 110.39 Mn
Sep 30, 2024 119.47 Mn
Jun 30, 2024 99.09 Mn
Mar 31, 2024 9.81 Mn
Jun 30, 2023 18.73 Mn
Mar 31, 2023 6.02 Mn